Reported encouraging early safety and efficacy data in ongoing dose escalation trial for ORIC-944 in combination with androgen receptor inhibitors in patients with mCRPC Entered into clinical trial ...
300474.SZ Changsha Jingjia Microelectronics Co., Ltd.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback